U.S.-driven growth to propel global cosmetics market to $704B by 2032
As AI-powered diagnostics, AR try-ons, and science-backed formulas continue to grow, U.S. retail will be a key driver in shaping global beauty innovation through 2032.
As AI-powered diagnostics, AR try-ons, and science-backed formulas continue to grow, U.S. retail will be a key driver in shaping global beauty innovation through 2032.
Patients can access weight management care for $49 per visit, no monthly subscription needed.
For U.S. retailers, probiotics are no longer limited to a niche supplement market.
The Vitamin Shoppe Supplement Awards honor the year's top brands and products, selected in partnership with the editors of Men's Health and Women's Health.
Construction is scheduled to begin in spring 2026, with the site expected to be fully operational by 2029.
Used by millions of patients worldwide, the KwikPen for single-patient use offers a new option for receiving Zepbound.
Using Simile’s AI simulations, CVS Health can test digital experiences in hours instead of weeks.
Bhattacharya will serve as acting director of the CDC while continuing to head NIH, marking the latest leadership shift within the Department of Health and Human Services.
Momentum in the U.S. grew driven by premium haircare, fragrance, and dermatologist-backed skincare.
In the U.S., growth is driven by mainstream retail and pharmacy channels, as sports nutrition products expand beyond specialty stores.
Beauty keeps outperforming many other consumer industries despite ongoing economic pressures.
As drugmakers implement 2026 price increases, SHARx argues that specialty pharmacy practices, not just list prices, often determine patient access and out-of-pocket costs.
The U.S. leads global retail pharmacy growth, driven by aging populations, increasing chronic diseases, and rapid digital pharmacy adoption.
Press Ganey’s inaugural Health Plan of the Year award honors Aetna’s sustained excellence in member experience, quality, and provider collaboration.
For pharmacy operators and healthcare stakeholders, the findings emphasize the need to maintain access to screening, timely referrals, and ongoing care during public health emergencies, especially for high-risk and newly diagnosed patients.
CVS Caremark stated that the change expands its broader biosimilar strategy.